Trial
NCT07102979
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chang Gung Memorial Hospital
Collaborators
—
Condition
Liver Fibrosis
Intervention
Ursodeoxycholic Acid (URSO)
Why stopped
Slow recruitment and exhaustion of available study funding.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-22